Institution
Pan American Health Organization
Healthcare•Havana, Cuba•
About: Pan American Health Organization is a healthcare organization based out in Havana, Cuba. It is known for research contribution in the topics: Population & Public health. The organization has 1500 authors who have published 2263 publications receiving 83705 citations. The organization is also known as: HO Regional Office for the Americas.
Topics: Population, Public health, Health care, Latin Americans, Vaccination
Papers published on a yearly basis
Papers
More filters
••
TL;DR: Pragmatic and management criteria are used to help develop the neonatal near miss concept and the most severe cases are identified and mortality is predicted with these criteria.
Abstract: The concept of neonatal near miss has been proposed as a tool for assessment of quality of care in neonates who suffered any life-threatening condition. However, there are no internationally agreed concepts or criteria for defining or identifying neonatal near miss. The purpose of this study was to perform a systematic review of studies and markers that are able to identify neonatal near miss cases and predict neonatal mortality. Electronic searches were performed in the Medline, Embase and Scielo databases, with no time or language restriction, until December 2014. The term “neonatal near miss” was used alone or in combination with terms related to neonatal morbidity/mortality and neonatal severity scores. Study selection criteria involved three steps: title, abstract and full text of the articles. Two researchers performed study selection and data extraction independently. Heterogeneity of study results did not permit the performance of meta-analysis. Following the inclusion and exclusion criteria adopted, only four articles were selected. Preterm and perinatal asphyxia were used as near miss markers in all studies. Health indicators on neonatal morbidity and mortality were extracted or estimated. The neonatal near miss rate was 2.6 to 8 times higher than the neonatal mortality rate. Pragmatic and management criteria are used to help develop the neonatal near miss concept. The most severe cases are identified and mortality is predicted with these criteria. Furthermore, the near miss concept can be used as a tool for evaluating neonatal care. It is the first step in building management strategies to reduce mortality and long-term sequelae.
55 citations
••
TL;DR: Several challenges are still to be overcome to ensure the elimination of FMD from the Americas by 2020, however, the goal is achievable.
Abstract: Foot-and-mouth disease (FMD) is a highly transmissible and economically devastating disease of cloven-hoofed livestock. Although vaccines are available and have been instrumental in eliminating the disease from most of the South American animal population, viral circulation still persists in some countries and areas, posing a threat to the advances of the last 60 years by the official veterinary services with considerable support of the livestock sectors. The importance of the disease for the social and economic development of the American continent led to the establishment in 1951 of the Pan American Centre for Foot-and-Mouth Disease (PANAFTOSA), which has been providing technical cooperation to countries for the elimination of the disease. The first FMD national elimination programmes were established in South America around the 1960s and 1970s. To advance the regional elimination efforts in the 1980s, countries agreed on a Plan of Action 1988–2009 of the Hemispheric Program for the Eradication of Foot-and-Mouth Disease. The Plan of Action 1988–2009 did not reach the goal of elimination from the continent; and a new Plan of Action 2011–2020 was developed in 2010 based on the experience acquired by the countries and PANAFTOSA during the past 60 years. This plan is now being implemented; several challenges are still to be overcome to ensure the elimination of FMD from the Americas by 2020, however, the goal is achievable.
55 citations
••
TL;DR: A reformulation of cervical cancer screening policies to be based on HPV testing using validated methods followed by cytologic triage is proposed, which would serve as the central component of a system that plays the dual role of providing screening and surveillance as integrated and complementary activities sharing centralized resources and coordination.
55 citations
••
TL;DR: The magnitude of iron deficiency anemia is estimated and strategies suggested by the Pan American Health Organization of the World Health Organization (PAHO/WHO) for adoption by individual countries are presented.
Abstract: Iron deficiency anemia is one of the major micronutrient deficiencies in the world Its etiology is well understood, and inexpensive solutions to the problem have been identified Nevertheless, the problem persists This paper estimates the magnitude of iron deficiency anemia and presents strategies suggested by the Pan American Health Organization of the World Health Organization (PAHOA/WHO) for adoption by individual countries
54 citations
••
TL;DR: Replacement of sdNVP with currently recommended regimens for PMTCT (WHO Options A, B, or B+) is necessary to reduce infant HIV infection risk in Zimbabwe.
Abstract: BACKGROUND: The Zimbabwean national prevention of mother-to-child HIV transmission (PMTCT) program provided primarily single-dose nevirapine (sdNVP) from 2002-2009 and is currently replacing sdNVP with more effective antiretroviral (ARV) regimens. METHODS: Published HIV and PMTCT models with local trial and programmatic data were used to simulate a cohort of HIV-infected pregnant/breastfeeding women in Zimbabwe (mean age 24.0 years mean CD4 451 cells/microL). We compared five PMTCT regimens at a fixed level of PMTCT medication uptake: 1) no antenatal ARVs (comparator); 2) sdNVP; 3) WHO 2010 guidelines using "Option A" (zidovudine during pregnancy/infant NVP during breastfeeding for women without advanced HIV disease; lifelong 3-drug antiretroviral therapy (ART) for women with advanced disease); 4) WHO "Option B" (ART during pregnancy/breastfeeding without advanced disease; lifelong ART with advanced disease); and 5) "Option B+:" lifelong ART for all pregnant/breastfeeding HIV-infected women. Pediatric (4-6 week and 18-month infection risk 2-year survival) and maternal (2- and 5-year survival life expectancy from delivery) outcomes were projected. RESULTS: Eighteen-month pediatric infection risks ranged from 25.8% (no antenatal ARVs) to 10.9% (Options B/B+). Although maternal short-term outcomes (2- and 5-year survival) varied only slightly by regimen maternal life expectancy was reduced after receipt of sdNVP (13.8 years) or Option B (13.9 years) compared to no antenatal ARVs (14.0 years) Option A (14.0 years) or Option B+ (14.5 years). CONCLUSIONS: Replacement of sdNVP with currently recommended regimens for PMTCT (WHO Options A B or B+) is necessary to reduce infant HIV infection risk in Zimbabwe. The planned transition to Option A may also improve both pediatric and maternal outcomes.
54 citations
Authors
Showing all 1503 results
Name | H-index | Papers | Citations |
---|---|---|---|
Marcello Tonelli | 128 | 701 | 115576 |
Stephen L. Hoffman | 104 | 458 | 38597 |
Peter Singer | 94 | 702 | 37128 |
James C. Anthony | 94 | 401 | 43875 |
Bruce G. Link | 92 | 307 | 45777 |
Andrew E. Skodol | 88 | 252 | 24975 |
Marie T. Ruel | 77 | 300 | 22862 |
Franco M. Muggia | 64 | 393 | 18587 |
María G. Guzmán | 63 | 272 | 15992 |
Rob McConnell | 63 | 250 | 17973 |
José M. Belizán | 53 | 198 | 11892 |
Agustin Conde-Agudelo | 52 | 87 | 12009 |
Denise L. Doolan | 49 | 199 | 10581 |
Brendan Flannery | 48 | 177 | 8004 |
Martha Sedegah | 45 | 120 | 9304 |